Little is known about the prevalence of persistent human infections by nontyphoidal Salmonella (NTS). Recently published study results indicate that a small fraction (at least 2.2%) of NTS-infected patients continue to shed Salmonella for an extended period of time (up to years). Despite the recommendation not to use antibiotics for the treatment of uncomplicated NTS-Salmonella infection, little treatment guidance is available. Clinical findings from a NTS-patient indicate that administration of synbiotics (probiotic bacteria plus prebiotic) might be considered as a treatment option. We report data of a patient who was treated with a synbiotic preparation containing nine different probiotic bacteria and the prebiotic fructooligosaccharides (FOS). Starting from day one of the treatment, the patient experienced an improvement of symptoms and was symptom-free at the end of a 10 days treatment course. After finishing the treatment, the stool proved to be Salmonella enterica serovar Typhimurium negative. In vitro pathogenic inhibition studies showed the inhibitory effects of the multistrain synbiotic mixture against S. Typhimurium. Growth of S. Typhimurium was also inhibited by individual bacterial strains making part of the composition of the mixture. However, he inhibitory effects of individual strains varied significantly, with those of Streptococcus thermophilus St-21 and Lactobacillus helveticus SP-27 exhibiting the strongest inhibitory effect. Persistent infections by S. Typhimurium are a severe concern for the affected patients. Besides the symptomatic burden, infected persons are banned from work in certain areas (e.g. food related service). In addition, patients with persistent S. Typhimurium infections are a threat for the public health in general, as they serve as a reservoir for NTS transmission. The findings indicate that treatment with a synbiotic preparation might provide a treatment option for persistent S. Typhimurium infections. More clinical data have to be gathered to confirm the relevance of this potential treatment approach.
Barreto, F.M., Colado Simao, A.N., Morimoto, H.K., Batisti Lozovoy, M.A., Dichi, I. and Helena da Silva Miglioranza, L., 2014. Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome. Nutrition 30: 939-942.
'Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome ' () 30 Nutrition : 939 -942.
Bartosch, S., Woodmansey, E.J., Paterson, J.C., McMurdo, M.E. and Macfarlane, G.T., 2005. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clinical Infectious Diseases 40: 28-37.
'Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria ' () 40 Clinical Infectious Diseases : 28 -37.
Buchwald, D.S. and Blaser, M.J., 1984. A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Reviews of Infectious Diseases 6: 345-356.
'A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella ' () 6 Reviews of Infectious Diseases : 345 -356.
Coburn, B., Grassl, G.A. and Finlay, B.B., 2007. Salmonella, the host and disease: a brief review. Immunology and Cell Biology 85: 112-118.
'Salmonella, the host and disease: a brief review ' () 85 Immunology and Cell Biology : 112 -118.
Collado, M.C., Meriluoto, J. and Salminen, S., 2007. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Letters in Applied Microbiology 45: 454-460.
'Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus ' () 45 Letters in Applied Microbiology : 454 -460.
Costa, G.N., Marcelino-Guimaraes, F.C., Vilas-Boas, G.T., Matsuo, T. and Miglioranza, L.H., 2014. Potential fate of ingested Lactobacillus plantarum and its occurrence in human feces. Applied and Environmental Microbiology 80: 1013-1019.
'Potential fate of ingested Lactobacillus plantarum and its occurrence in human feces ' () 80 Applied and Environmental Microbiology : 1013 -1019.
Daniel, C., Poiret, S., Goudercourt, D., Dennin, V., Leyer, G. and Pot, B., 2006. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Applied and Environmental Microbiology 72: 5799-5805.
'Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model ' () 72 Applied and Environmental Microbiology : 5799 -5805.
De Keersmaecker, S.C., Verhoeven, T.L., Desair, J., Marchal, K., Vanderleyden, J. and Nagy, I., 2006. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella Typhimurium is due to accumulation of lactic acid. FEMS Microbiology Letters 259: 89-96.
'Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella Typhimurium is due to accumulation of lactic acid ' () 259 FEMS Microbiology Letters : 89 -96.
De Vuyst, L., 2006. In vitro and in vivo antibacterial activity of probiotics against Salmonella Typhimurium, mechanisms of action, and kinetic analysis. PROPATH Report Summary. Available at: http://cordis.europa.eu/result/rcn/43354_en.html.
Ding, W.K. and Shah, N.P., 2007. Acid, bile, and heat tolerance of free and microencapsulated probiotic bacteria. Journal of Food Science 72: M446-450.
'Acid, bile, and heat tolerance of free and microencapsulated probiotic bacteria ' () 72 Journal of Food Science : M446 -450.
Engelbrektson, A.L., Korzenik, J.R., Sanders, M.E., Clement, B.G., Leyer, G., Klaenhammer, T.R. and Kitts, C.L., 2006. Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiology Ecology 57: 239-250.
'Analysis of treatment effects on the microbial ecology of the human intestine ' () 57 FEMS Microbiology Ecology : 239 -250.
Foligne, B., Nutten, S., Grangette, C., Dennin, V., Goudercourt, D., Poiret, S., Dewulf, J., Brassart, D., Mercenier, A. and Pot, B., 2007a. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World Journal of Gastroenterology 13: 236-243.
'Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria ' () 13 World Journal of Gastroenterology : 236 -243.
Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A., Chareyre, F., Sirard, J.C., Pot, B. and Grangette, C., 2007b. A key role of dendritic cells in probiotic functionality. PLoS ONE 2: e313.
'A key role of dendritic cells in probiotic functionality ' () 2 PLoS ONE : e313.
Franco, T.S., Garcia, S., Hirooka, E.Y., Ono, Y.S. and Dos Santos, J.S., 2011. Lactic acid bacteria in the inhibition of Fusarium graminearum and deoxynivalenol detoxification. Journal of Applied Microbiology 111: 739-748.
'Lactic acid bacteria in the inhibition of Fusarium graminearum and deoxynivalenol detoxification ' () 111 Journal of Applied Microbiology : 739 -748.
Fuller, R., 1989. Probiotics in man and animals. Journal of Applied Bacteriology 66: 365-378.
'Probiotics in man and animals ' () 66 Journal of Applied Bacteriology : 365 -378.
Galanis, E., Lo Fo Wong, D.M., Patrick, M.E., Binsztein, N., Cieslik, A., Chalermchikit, T., Aidara-Kane, A., Ellis, A., Angulo, F.J., Wegener, H.C. and World Health Organisation, 2006. Web-based surveillance and global Salmonella distribution, 2000-2002. Emerging Infectious Diseases 12: 381-388.
'Web-based surveillance and global Salmonella distribution, 2000-2002 ' () 12 Emerging Infectious Diseases : 381 -388.
Gill, H. and Prasad, J., 2008. Probiotics, immunomodulation, and health benefits. Advances in Experimental Medicine and Biology 606: 423-454.
'Probiotics, immunomodulation, and health benefits ' () 606 Advances in Experimental Medicine and Biology : 423 -454.
Jandhyala, S.M., Talukdar, R., Subramanyam, C., Vuyyuru, H., Sasikala, M. and Nageshwar Reddy, D., 2015. Role of the normal gut microbiota. World Journal of Gastroenterology 21: 8787-8803.
'Role of the normal gut microbiota ' () 21 World Journal of Gastroenterology : 8787 -8803.
Kang, H.J. and Im, S.H., 2015. Probiotics as an immune modulator. Journal of Nutritional Science and Vitaminology 61: S103-105.
'Probiotics as an immune modulator ' () 61 Journal of Nutritional Science and Vitaminology : S103 -105.
Lollo, P.C., Cruz, A.G., Morato, P.N., Moura, C.S., Carvalho-Silva, L.B., Oliveira, C.A., Faria, J.A. and Amaya-Farfan, J., 2012. Probiotic cheese attenuates exercise-induced immune suppression in Wistar rats. Journal of Dairy Science 95: 3549-3558.
'Probiotic cheese attenuates exercise-induced immune suppression in Wistar rats ' () 95 Journal of Dairy Science : 3549 -3558.
Lönnermark, E., Lappas, G., Friman, V., Wold, A.E., Backhaus, E. and Adlerberth, I., 2015. Effects of probiotic intake and gender on nontyphoid Salmonella infection. Journal of Clinical Gastroenterology 49: 116-123.
'Effects of probiotic intake and gender on nontyphoid Salmonella infection ' () 49 Journal of Clinical Gastroenterology : 116 -123.
Makras, L., Triantafyllou, V., Fayol-Messaoudi, D., Adriany, T., Zoumpopoulou, G., Tsakalidou, E., Servin, A. and De Vuyst, L., 2006. Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds. Research in Microbiology 157: 241-247.
'Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds ' () 157 Research in Microbiology : 241 -247.
Marzel, A., Desai, P.T., Goren, A., Schorr, Y.I., Nissan, I., Porwollik, S., Valinsky, L., McClelland, M., Rahav, G. and Gal-Mor, O., 2016. Persistent infections by nontyphoidal Salmonella in humans: epidemiology and genetics. Clinical Infectious Diseases 62: 879-886.
'Persistent infections by nontyphoidal Salmonella in humans: epidemiology and genetics ' () 62 Clinical Infectious Diseases : 879 -886.
Matsubara, V.H., Ishikawa, K.H., Ando-Suguimoto, E.S., Bueno-Silva, B., Nakamae, A.E.M. and Mayer, M.P.A., 2017. Probiotic bacteria alter pattern-recognition receptor expression and cytokine profile in a human macrophage model challenged with Candida albicans and lipopolysaccharide. Frontiers in Microbiology 8: 2280.
'Probiotic bacteria alter pattern-recognition receptor expression and cytokine profile in a human macrophage model challenged with Candida albicans and lipopolysaccharide ' () 8 Frontiers in Microbiology : 2280.
Miyazima, T.Y., Ishikawa, K.H., Mayer, M., Saad, S. and Nakamae, A., 2017. Cheese supplemented with probiotics reduced the Candida levels in denture wearers-RCT. Oral Diseases 23: 919-925.
'Cheese supplemented with probiotics reduced the Candida levels in denture wearers-RCT ' () 23 Oral Diseases : 919 -925.
Paineau, D., Carcano, D., Leyer, G., Darquy, S., Alyanakian, M.A., Simoneau, G., Bergmann, J.F., Brassart, D., Bornet, F. and Ouwehand, A.C., 2008. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunology and Medical Microbiology 53: 107-113.
'Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial ' () 53 FEMS Immunology and Medical Microbiology : 107 -113.
Paroschi, T.P., Breganó, J.W., Simão, A.N.C., Dichi, I. and Miglioranza, L.H.S., 2015. Effects of sulfasalazine, Lactobacillus plantarum (Lp-115) and fish oil in experimental colitis. SM Journal of Food and Nutritional Disorders 1: 1005.
'Effects of sulfasalazine, Lactobacillus plantarum (Lp-115) and fish oil in experimental colitis ' () 1 SM Journal of Food and Nutritional Disorders : 1005.
Parry, C.M., Hien, T.T., Dougan, G., White, N.J. and Farrar, J.J., 2002. Typhoid fever. New England Journal of Medicine 347: 1770-1782.
'Typhoid fever ' () 347 New England Journal of Medicine : 1770 -1782.
Piatek, J., Gibas-Dorna, M., Olejnik, A., Krauss, H., Wierzbicki, K., Zukiewicz-Sobczak, W. and GÅowacki, M., 2012. The viability and intestinal epithelial cell adhesion of probiotic strain combination â in vitro study. Annals of Agricultural and Environmental Medicine 19: 99-102.
'The viability and intestinal epithelial cell adhesion of probiotic strain combination â in vitro study ' () 19 Annals of Agricultural and Environmental Medicine : 99 -102.
Rao, R.K. and Samak, G., 2013. Protection and restitution of gut barrier by probiotics: nutritional and clinical implications. Current Nutrition and Food Science 9: 99-107.
'Protection and restitution of gut barrier by probiotics: nutritional and clinical implications ' () 9 Current Nutrition and Food Science : 99 -107.
Schwendicke, F., Korte, F., Dorfer, C.E., Kneist, S., Fawzy El-Sayed, K. and Paris, S., 2017. Inhibition of Streptococcus mutans growth and biofilm formation by probiotics in vitro. Caries Research 51: 87-95.
'Inhibition of Streptococcus mutans growth and biofilm formation by probiotics in vitro ' () 51 Caries Research : 87 -95.
Sirinavin, S. and Garner, P., 1999. Antibiotics for treating Salmonella gut infections. Cochrane Database of Systematic Reviews. DOI: https://doi.org/10.1002/14651858.CD001167.
Smith, A.R., Macfarlane, G.T., Reynolds, N., OâMay, G.A., Bahrami, B. and Macfarlane, S., 2012. Effect of a synbiotic on microbial community structure in a continuous culture model of the gastric microbiota in enteral nutrition patients. FEMS Microbiology Ecology 80: 135-145.
'Effect of a synbiotic on microbial community structure in a continuous culture model of the gastric microbiota in enteral nutrition patients ' () 80 FEMS Microbiology Ecology : 135 -145.
Strus, M., 1998. A new method for evaluation of the antagonistic action of bacterial lactic acid (LAB) on selected pathogenic indicator bacteria. Medycyna Doswiadczalna i Mikrobiologia 50: 123-130.
'A new method for evaluation of the antagonistic action of bacterial lactic acid (LAB) on selected pathogenic indicator bacteria ' () 50 Medycyna Doswiadczalna i Mikrobiologia : 123 -130.
Strus, M., Pakosz, K., Gosciniak, H., Przondo-Mordarska, A., Rozynek, E., Pituch, H., Meisel-Mikolajczyk, F. and Heczko, P.B., 2001. Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile). Medycyna Doswiadczalna i Mikrobiologia 53: 133-142.
'Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile) ' () 53 Medycyna Doswiadczalna i Mikrobiologia : 133 -142.
Timmerman, H.M., Koning, C.J., Mulder, L., Rombouts, F.M. and Beynen, A.C., 2004. Monostrain, multistrain and multispecies probiotics â a comparison of functionality and efficacy. International Journal of Food Microbiology 96: 219-233.
'Monostrain, multistrain and multispecies probiotics â a comparison of functionality and efficacy ' () 96 International Journal of Food Microbiology : 219 -233.
Turroni, S., Vitali, B., Bendazzoli, C., Candela, M., Gotti, R., Federici, F., Pirovano, F. and Brigidi, P., 2007. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. Journal of Applied Microbiology 103: 1600-1609.
'Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus ' () 103 Journal of Applied Microbiology : 1600 -1609.
Vigsnaes, L.K., Nakai, H., Hemmingsen, L., Andersen, J.M., Lahtinen, S.J., Rasmussen, L.E., Hachem, M.A., Petersen, B.O., Duus, J.O., Meyer, A.S., Licht, T.R. and Svensson, B., 2013. In vitro growth of four individual human gut bacteria on oligosaccharides produced by chemoenzymatic synthesis. Food and Function 4: 784-793.
'In vitro growth of four individual human gut bacteria on oligosaccharides produced by chemoenzymatic synthesis ' () 4 Food and Function : 784 -793.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 360 | 125 | 17 |
| PDF Views & Downloads | 319 | 116 | 6 |
Little is known about the prevalence of persistent human infections by nontyphoidal Salmonella (NTS). Recently published study results indicate that a small fraction (at least 2.2%) of NTS-infected patients continue to shed Salmonella for an extended period of time (up to years). Despite the recommendation not to use antibiotics for the treatment of uncomplicated NTS-Salmonella infection, little treatment guidance is available. Clinical findings from a NTS-patient indicate that administration of synbiotics (probiotic bacteria plus prebiotic) might be considered as a treatment option. We report data of a patient who was treated with a synbiotic preparation containing nine different probiotic bacteria and the prebiotic fructooligosaccharides (FOS). Starting from day one of the treatment, the patient experienced an improvement of symptoms and was symptom-free at the end of a 10 days treatment course. After finishing the treatment, the stool proved to be Salmonella enterica serovar Typhimurium negative. In vitro pathogenic inhibition studies showed the inhibitory effects of the multistrain synbiotic mixture against S. Typhimurium. Growth of S. Typhimurium was also inhibited by individual bacterial strains making part of the composition of the mixture. However, he inhibitory effects of individual strains varied significantly, with those of Streptococcus thermophilus St-21 and Lactobacillus helveticus SP-27 exhibiting the strongest inhibitory effect. Persistent infections by S. Typhimurium are a severe concern for the affected patients. Besides the symptomatic burden, infected persons are banned from work in certain areas (e.g. food related service). In addition, patients with persistent S. Typhimurium infections are a threat for the public health in general, as they serve as a reservoir for NTS transmission. The findings indicate that treatment with a synbiotic preparation might provide a treatment option for persistent S. Typhimurium infections. More clinical data have to be gathered to confirm the relevance of this potential treatment approach.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 360 | 125 | 17 |
| PDF Views & Downloads | 319 | 116 | 6 |